Katayoon Shirneshan

763 total citations
21 papers, 271 citations indexed

About

Katayoon Shirneshan is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Katayoon Shirneshan has authored 21 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Katayoon Shirneshan's work include Acute Myeloid Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Katayoon Shirneshan is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Katayoon Shirneshan collaborates with scholars based in Germany, Austria and United Kingdom. Katayoon Shirneshan's co-authors include Ibrahim M. Adham, Ozanna Burnicka-Turek, Wolfgang Engel, Friederike Braulke, Julie Schanz, Detlef Haase, Sabine Hombach‐Klonisch, Thomas Klonisch, Belal A. Mohamed and Thatchawan Thanasupawat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Endocrinology.

In The Last Decade

Katayoon Shirneshan

20 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katayoon Shirneshan Germany	10	118	82	79	57	30	21	271
Helena Mörse Sweden	10	83 0.7×	76 0.9×	169 2.1×	48 0.8×	36 1.2×	19	312
Stella J. Nylund Finland	7	172 1.5×	89 1.1×	33 0.4×	38 0.7×	32 1.1×	11	289
Cecília Correia Portugal	12	124 1.1×	92 1.1×	32 0.4×	53 0.9×	28 0.9×	25	267
Céline Bourgne France	9	110 0.9×	44 0.5×	60 0.8×	12 0.2×	33 1.1×	26	271
Heather C. Murray Australia	7	99 0.8×	55 0.7×	37 0.5×	5 0.1×	25 0.8×	17	210
Weiwei Cheng China	5	138 1.2×	12 0.1×	45 0.6×	23 0.4×	12 0.4×	7	360
Maria Bouvy‐Liivrand Finland	11	243 2.1×	45 0.5×	54 0.7×	18 0.3×	12 0.4×	14	365
Xunqiang Yin China	9	126 1.1×	25 0.3×	101 1.3×	15 0.3×	10 0.3×	16	362
Siobhan Rice United Kingdom	6	106 0.9×	60 0.7×	64 0.8×	17 0.3×	12 0.4×	11	230
Nicholas Hickson United Kingdom	8	66 0.6×	35 0.4×	20 0.3×	54 0.9×	7 0.2×	10	185

Countries citing papers authored by Katayoon Shirneshan

Since Specialization

Citations

This map shows the geographic impact of Katayoon Shirneshan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katayoon Shirneshan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katayoon Shirneshan more than expected).

Fields of papers citing papers by Katayoon Shirneshan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katayoon Shirneshan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katayoon Shirneshan. The network helps show where Katayoon Shirneshan may publish in the future.

Co-authorship network of co-authors of Katayoon Shirneshan

This figure shows the co-authorship network connecting the top 25 collaborators of Katayoon Shirneshan. A scholar is included among the top collaborators of Katayoon Shirneshan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katayoon Shirneshan. Katayoon Shirneshan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shumilov, Evgenii, Björn Häupl, Katayoon Shirneshan, et al.. (2025). Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling. Leukemia. 39(12). 3026–3036.

Ganster, Christina, Katayoon Shirneshan, Elżbieta Brzuszkiewicz, et al.. (2024). Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real‐world cohort of patients with lower‐risk MDS. HemaSphere. 8(9). e70014–e70014. 1 indexed citations

Mallo, Mar, Heinz Tuechler, Leonor Arenillas, et al.. (2023). Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype. SHILAP Revista de lepidopterología. 4(2). 446–449. 3 indexed citations

Braulke, Friederike, Julie Schanz, Katayoon Shirneshan, et al.. (2022). Cytogenetic peripheral blood monitoring in azacitidine treated patients with high-risk MDS/sAML: A monocentric real-world experience. Leukemia Research. 124. 106996–106996. 3 indexed citations

Crisà, Elena, Austin Kulasekararaj, Vera Ademà, et al.. (2020). Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7. Leukemia. 34(9). 2441–2450. 10 indexed citations

Schanz, Julie, Christa Fonatsch, Friederike Braulke, et al.. (2018). Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders. Blood Cancer Journal. 8(3). 28–28. 16 indexed citations

Schrader, Alexandra, Katharina Meyer, Ailine Stolz, et al.. (2016). Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data. Oncotarget. 7(30). 47061–47081. 8 indexed citations

Ganster, Christina, Katayoon Shirneshan, Gabriela Salinas-Riester, et al.. (2015). Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS. Leukemia Research. 39(10). 1079–1087. 9 indexed citations

Ganster, Christina, Klaus Jung, Friederike Braulke, et al.. (2015). New data shed light on Y‐loss‐related pathogenesis in myelodysplastic syndromes. Genes Chromosomes and Cancer. 54(12). 717–724. 35 indexed citations

10.

Schanz, Julie, Friederike Braulke, Katayoon Shirneshan, et al.. (2013). Therapy With Demethylating Agents Significantly Improves Overall- and AML-Free Survival In Patients With MDS Classified As High-Risk By IPSS Or Very High Risk By IPSS-R and Partial Or Total Monosomy 7-Results From a German Multicenter Study. Blood. 122(21). 2784–2784. 1 indexed citations

11.

Varges, Daniela, Walter Schulz‐Schaeffer, Wiebke M. Wemheuer, et al.. (2013). Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene. Journal of Neurology. 260(7). 1871–1879. 1 indexed citations

12.

Shirneshan, Katayoon, Uwe Platzbecker, Florian Nolte, et al.. (2013). Monitoring By Chromosome Banding Analysis (CBA) and FISH Of Circulating CD34+ Cells In Low-Risk MDS Patients Treated In The Le-Mon-5 Study With Lenalidomide Monotherapy Reveals 82% Cytogenetic Responders With Different Response – , Evolutionary -, and Remission Patterns and No Increased Karyotype Evolution (KE). Blood. 122(21). 2783–2783. 2 indexed citations

13.

Burnicka-Turek, Ozanna, Belal A. Mohamed, Katayoon Shirneshan, et al.. (2012). INSL5-Deficient Mice Display an Alteration in Glucose Homeostasis and an Impaired Fertility. Endocrinology. 153(10). 4655–4665. 54 indexed citations

14.

Platzbecker, Uwe, Christina Ganster, Jürgen Neesen, et al.. (2011). Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities – Results of the “AZALE” Trial,. Blood. 118(21). 3799–3799. 4 indexed citations

15.

Braulke, Friederike, Julie Schanz, Klaus Jung, et al.. (2010). FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients. Leukemia Research. 34(10). 1296–1301. 18 indexed citations

16.

Zechner, Ulrich, Jessica Nolte, Katayoon Shirneshan, et al.. (2009). Comparative methylation profiles and telomerase biology of mouse multipotent adult germline stem cells and embryonic stem cells. Molecular Human Reproduction. 15(6). 345–353. 33 indexed citations

17.

Burnicka-Turek, Ozanna, Katayoon Shirneshan, Paweł Grzmil, et al.. (2009). Inactivation of Insulin-Like Factor 6 Disrupts the Progression of Spermatogenesis at Late Meiotic Prophase. Endocrinology. 150(9). 4348–4357. 38 indexed citations

18.

Shirneshan, Katayoon, Stefan Binder, Detlef Böhm, et al.. (2008). Directed overexpression of insulin in Leydig cells causes a progressive loss of germ cells. Molecular and Cellular Endocrinology. 295(1-2). 79–86. 11 indexed citations

19.

Schulz, Stefan, et al.. (2008). Prenatal diagnosis of Roberts syndrome and detection of an ESCO2 frameshift mutation in a Pakistani family. Prenatal Diagnosis. 28(1). 42–45. 12 indexed citations

20.

Gläser, Birgitta, Katayoon Shirneshan, Karin Bink, et al.. (2003). Molecular cytogenetic analysis of a de novo balanced X;autosome translocation: Evidence for predominant inactivation of the derivative X chromosome in a girl with multiple malformations. American Journal of Medical Genetics Part A. 126A(3). 229–236. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact